Noticias sobre VIH/SIDA

HIV and chronic HCV co-infection prevalence in England highest among MSM

Aidsmap news - English - Mié, 15/08/2018 - 9:40am
Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published in HIV Medicine. Approximately two-thirds of prevalent HIV infections among people with chronic HCV involved MSM, and the majority of these people
Categorías: VIH/SIDA

Treatment with modern antiretrovirals doesn't increase the risk of hypertension

Aidsmap news - English - Mar, 14/08/2018 - 9:40am
There is no strong evidence that treatment with antiretrovirals significantly increases the risk of hypertension, investigators from the D:A:D study report in HIV Medicine.  After taking into account demographic and traditional risk factors, only two older anti-HIV drugs had a significant association with hypertension. “Using data from a large, heterogeneous cohort with information on a
Categorías: VIH/SIDA

PrEP use taking off in Thailand and Vietnam

Aidsmap news - English - Lun, 13/08/2018 - 9:10am
PrEP use is accelerating among men who have sex with men (MSM) and transgender women (TGW) in two south-east Asian countries where it is receiving funding and government support, the AIDS2018 conference heard two weeks ago. As with PrEP in other settings, one of the challenges is retention; in Thailand only half of the
Categorías: VIH/SIDA

ONUSIDA celebra el nombramiento de Michelle Bachelet como alta comisionada de las Naciones Unidas para los Derechos Humanos

UNAIDS | Press Statements - Vie, 10/08/2018 - 11:15am
ONUSIDA celebra el nombramiento de Michelle Bachelet, expresidenta de Chile, como jefa de derechos humanos de las Naciones Unidas.
Categorías: VIH/SIDA

People with HIV receiving methadone and HIV drugs spend less time with detectable viral load

Aidsmap news - English - Vie, 10/08/2018 - 9:50am
People on methadone maintenance treatment spent less time with a detectable viral load above 1500 copies/ml, potentially reducing the risk of HIV transmission, a study presented at last month’s 22nd International AIDS Conference has found. Methadone is an opioid substitution treatment prescribed to minimise the harms associated with the use of heroin or other opioids.
Categorías: VIH/SIDA

Studies show dolutegravir monotherapy is an unsafe switch option

Aidsmap news - English - Jue, 09/08/2018 - 9:20am
Using dolutegravir alone, as maintenance treatment after achieving undetectable viral load on a three-drug regimen, results in an unacceptable rate of viral rebound and is unethical in the view of many experts, the 22nd International AIDS Conference (AIDS 2018) heard last month. The integrase inhibitor dolutegravir is a preferred component of three-drug antiretroviral regimens, along
Categorías: VIH/SIDA

HIV infection is a risk factor for liver fat accumulation

Aidsmap news - English - Mié, 08/08/2018 - 10:20am
People living with HIV are about twice as likely to develop steatosis, or fat accumulation in the liver, even if they don't have hepatitis B or C co-infection, according to a study presented at the recent 22nd International AIDS Conference (AIDS 2018) in Amsterdam.  Liver disease is a major cause of morbidity and mortality among people living with HIV. Hepatitis
Categorías: VIH/SIDA

Diarrhoea continues to affect the quality of life of people with HIV in the modern treatment era

Aidsmap news - English - Mar, 07/08/2018 - 9:50am
A meta-analysis of 38 clinical trials of antiretroviral therapies (ART) conducted in the past decade found that an average of 17% of study participants suffered from diarrhoea, with no improvement in more recent studies. Diarrhoea has multiple causes and only some of these cases are likely to be due to the drugs used
Categorías: VIH/SIDA

PrEP spreads across Africa - slowly

Aidsmap news - English - Lun, 06/08/2018 - 11:50am
This year, 2018, will be the year that a really significant number of people in Africa started HIV pre-exposure prophylaxis (PrEP), the AIDS2018 conference in Amsterdam heard last week. PrEP was probably the dominant subject at this year’s conference – there were far more sessions devoted to it than any other topic – and
Categorías: VIH/SIDA

Young adults with life-long HIV have a higher risk of cancer

Aidsmap news - English - Mié, 01/08/2018 - 12:00pm
Adolescents and young adults who acquired HIV before or at birth had a 13-fold higher likelihood of developing cancer and a 9-fold higher risk of death, according to a study presented at the 22nd International AIDS Conference (AIDS 2018) last week in Amsterdam. Development of cancer was associated with lack of viral suppression
Categorías: VIH/SIDA

Increase in STIs in PrEP users is concentrated in a minority of men and is partly due to more STI screening

Aidsmap news - English - Mié, 01/08/2018 - 9:30am
There were significant increases in bacterial sexually transmitted infections (STIs) in gay and bisexual men taking pre-exposure prophylaxis (PrEP) for the first time in Victoria, Australia, but infections were concentrated in a subset of PrEP users – 13% of the men had 53% of the STI diagnoses. Moreover, there was a 48% increase in
Categorías: VIH/SIDA

Unintended pregnancies and desire for children: reproductive health needs of women living with HIV

Aidsmap news - English - Mié, 01/08/2018 - 9:00am
The needs for safe conception services and a wider choice of contraception for women living with HIV in sub-Saharan Africa were highlighted last week at the 22nd International AIDS Conference in Amsterdam. Recent international and country-level guidance on the use of the antiretroviral drug dolutegravir with effective contraception, due to the
Categorías: VIH/SIDA

Most adolescent PrEP users in US are young women

Aidsmap news - English - Mar, 31/07/2018 - 3:00pm
Only 1.5% of people who have used pre-exposure prophylaxis (PrEP) in the United States are age 17 or younger, and more than 80% of them are girls and young women, according to estimates from Gilead Sciences presented last week at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.Given that new HIV
Categorías: VIH/SIDA

Dolutegravir brings faster viral suppression in late pregnancy

Aidsmap news - English - Mar, 31/07/2018 - 1:50pm
Among 60 women presenting to routine antenatal clinics in Kampala, Uganda and Cape Town, South Africa with undiagnosed HIV in late pregnancy, viral load suppression was faster in those starting dolutegravir (DTG)- compared to efavirenz (EFV)-based antiretroviral therapy (ART). Dr Saye Khoo, on behalf of the DolPHIN-1 study group, presented
Categorías: VIH/SIDA

AIDS 2018: Buenos niveles de adherencia a cabotegravir/rilpivirina inyectable de administración mensual o bimestral

gTt-VIH - La noticia del día - Mar, 31/07/2018 - 11:06am

La gran mayoría de personas con el VIH que participaron en la fase II del estudio LATTE-2 mantuvieron un nivel de adherencia elevado a la formulación inyectable de cabotegravir y rilpivirina de administración mensual o bimestral para el tratamiento de la infección por el VIH. Este es el principal resultado de un estudio presentado en la 22 Conferencia Internacional del Sida (AIDS 2018), celebrada la semana pasada en Ámsterdam (Países Bajos).

LATTE-2 es un estudio en fase IIb, multicéntrico y de tipo abierto diseñado para evaluar la eficacia del uso de la combinación compuesta por cabotegravir y rilpivirina en una formulación inyectable de administración mensual o bimestral en pacientes naive a los antirretrovirales.

Categorías: VIH/SIDA

Digital innovations are promoting HIV testing and prevention to MSM in Asia

Aidsmap news - English - Lun, 30/07/2018 - 6:00pm
Innovative health promotion interventions engaging men who have sex with men (MSM) in south east Asia through social media, apps, online marketing, video tools and phone services were highlighted at the 22nd International AIDS Conference (AIDS 2018) last week. In contexts where same-sex behaviour often remains stigmatised, digital connections are increasingly important.Lord-Art Lomarda said that
Categorías: VIH/SIDA

Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 weeks of follow-up

Aidsmap news - English - Lun, 30/07/2018 - 5:40pm
The experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) doravirine was more effective than darunavir/ritonavir over nearly two years of follow-up, according to results of a phase 3 study presented to the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. After 96 weeks, viral suppression (below 50 copies/ml) was observed in 73%
Categorías: VIH/SIDA

AIDS 2018: Altas tasas de reinfección por hepatitis C en HSH con el VIH de Madrid tras haber curado la afección hepática

gTt-VIH - La noticia del día - Lun, 30/07/2018 - 4:09pm

Un estudio español presentado en la 22 Conferencia Internacional del Sida (AIDS 2018), celebrada la semana pasada en Ámsterdam (Países Bajos), ha reflejado la existencia de unas tasas elevadas de reinfección por el virus de la hepatitis C (VHC) entre la población de hombres gais, bisexuales y otros hombres que practican sexo con hombres (HSH) con el VIH tras haberse curado la infección hepática con antivirales de acción directa (DAA, en sus siglas en inglés). El estudio ha sido realizado por investigadores del Grupo de Estudio de Sida (GeSIDA) y la Red de Investigación del SIDA (RIS), en colaboración con la Subdirección General de Farmacia y Productos Sanitarios de la Comunidad de Madrid.

Categorías: VIH/SIDA

Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed

Aidsmap news - English - Lun, 30/07/2018 - 2:40pm
A daily dose of the boosted protease inhibitor darunavir/ritonavir 400/100mg is at least as effective as therapy with lopinavir/ritonavir for people switching treatment while virally suppressed, according to South African research presented to the 22nd International AIDS Conference (AIDS 2018) in Amsterdam. The darunavir dose was cut by half without
Categorías: VIH/SIDA